A Virtual Dietary Intervention (MIND-BC) for Reducing Cancer-related Cognitive Impairment in Women Undergoing Treatment for Stage II-IV Breast Cancer

This clinical trial tests whether a virtual dietary intervention (the Mediterranean-DASH Intervention for Neurodegenerative Delay [MIND] - Breast Cancer [BC] diet) works to reduce cancer-related cognitive impairment in women undergoing treatment for stage II-IV breast cancer. Patients undergoing treatment for cancer often experience side effects that reduce their quality of life. Cancer-related cognitive impairment is one of the most common and serious side effects associated with cancer treatment. The MIND diet targets ten key food groups that have been shown to be protective of cognitive function (leafy greens, other vegetables, beans, whole grains, berries, nuts, non-fried fish, non-fried poultry, olive and canola oils, and wine). Patients receiving the MIND-BC diet intervention are taught specific behavior change techniques to address self-efficacy, self-monitoring, social support, goal setting, and removing barriers to support healthy eating patterns. The virtual MIND-BC dietary intervention may be an effective and accessible option for reducing cognitive impairment in women undergoing treatment for stage II-IV breast cancer.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05984888.

Trial PhaseNo phase specified

Trial Typesupportive care

Lead OrganizationOhio State University Comprehensive Cancer Center

Principal InvestigatorTonya Orchard

• Primary IDOSU-22367
• Secondary IDsNCI-2023-10600, 2023C0053
• ClinicalTrials.gov IDNCT05984888